|
Quotes & Info
|
| RGDX > SEC Filings for RGDX > Form 8-K on 21-Mar-2013 | All Recent SEC Filings |
21-Mar-2013
Results of Operations and Financial Condition, Financial Statements and Exh
On March 21, 2013, Response Genetics, Inc. (the "Company") issued a press release announcing its financial results for the fiscal quarter and fiscal year ended December 31, 2012. A copy of the press release is attached hereto as Exhibit 99.1. The information in this Current Report on Form 8-K and the Exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act, except as expressly set forth by specific reference in such a filing.
(d) Exhibits.
Exhibit # Description
99.1* Copy of the Company's press release, issued March 21, 2013.
* Exhibit 99.1 is being furnished to the Securities and Exchange Commission (the "SEC") pursuant to Item 2.02 and is not being filed with the SEC. Therefore, this Exhibit is not incorporated by reference in any of the registrant's other SEC filings.
|
|